Biosensor-integrated transposon mutagenesis reveals rv0158 as a coordinator of redox homeostasis in Mycobacterium tuberculosis (ChIP-Seq)

Transcriptomic analysis of untreated log-phase Mtb H37Rv, Mtbrv0158 Knockout strain and Mtbrv0158 complemented strain

Dynamin-like proteins are essential for vesicle biogenesis in Mycobacterium tuberculosis.

Genome-wide host loci regulate M. tuberculosis fitness in immunodivergent mice.

The response of WT, ∆rip1, and ∆sigL strains of Mycobacterium tuberculosis to dipyridyl treatment

A next generation three-dimensional hydrogel-based culture system for studying host-pathogen interaction and drug efficacy in tuberculosis

Iron deprivation enhances transcriptional responses to growth arrest of Mycobacterium tuberculosis

RNA-seq analysis of various strains of Mycobacterium tuberculosis under normal and acidic stress.

Transcriptomic changes associated with deletion of Rv3143 from Mycobacterium tuberculosis H37Rv in relation to wild-type strain grown in 7H9/OADC medium

Commonalities of Mycobacterium tuberculosis Transcriptomes in Response to Defined Persisting Macrophage Stresses

Expression and 5' end mapping data for Mycobacterium tuberculosis with deletion of Rv2752c/rnj

Alterations in Mycobacterium tuberculosis transcriptome at the site of infection in BTB tuberculosis

Transcriptome profiling of Mycobacterium tuberculosis H37Rv to primary drugs

Mycobacterium tuberculosis transcriptional response to Pyrazinoic acid

Transcriptomic analysis of Wild type M.tb H37Rv, HigB KO M.tb H37Rv and complemented Hig B KO M.tb H37Rv

ANALYSIS OF THE GENETIC EXPRESSION PROFILES OF SENSITIVE AND MULTIPHARMACORRESISTANT Mycobacterium tuberculosis CLONES EXPOSED TO NEW COMPOUNDS

Temporal response of Mycobacterium tuberculosis H37Rv to vitamin C exposure in THP-1 macrophages.

Global gene expression profiling of M. tuberculosis H37Rv and the isogenic regX3-inactivated mutant (DregX3) grown in phosphate enriched or phosphate-limited medium

RNA sequencing of Mtb H37Rv, MtbΔsufR and sufR complemented mycobacterium tuberculosis strains upon treatment with 0.5 mM DETA-NO.

Validation of RelMtb as a target for Mycobacterium tuberculosis persisters